31. OC-0314: Can SBRT be a viable therapeutic option for unresectable pancreatic adenocarcinoma? Results of phase II study. (April 2015) Authors: Comito, T.; Clerici, E.; D'Agostino, G.R.; Navarria, P.; Tozzi, A.; Iftode, C.; Franzese, C.; Villa, E.; De Rose, F.; Ascolese, A.M.; Lobefalo, F.; Zerbi, A.; Rimassa, L.; Carnaghi, C.; Tronconi, M.C.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. OC-0373: SBRT versus TAE/TACE in Hepatocellular Carcinoma: results from a Phase III trial (NCT02323360). (November 2020) Authors: Comito, T.; Loi, M.; Franzese, C.; Clerici, E.; Pedicini, V.; Poretti, D.; Solbiati, L.; Rimassa, L.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. OC-0524: Phase II trial on SBRT for Liver Metastases: Long-term outcomes and prognostic factors of survival. (May 2017) Authors: Comito, T.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.R.; Franceschini, D.; De Rose, F.; Ascolese, A.; Di Brina, L.; Tomatis, S.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. OC.02.6 EUS-GUIDED PLACEMENT OF NEW GOLDEN FIDUCIAL MARKERS IN STEREOTACTIC BODY RADIATION THERAPY IN LOCALLY ADVANCED PANCREATIC CANCER: PRELIMINARY RESULTS OF FEASIBILITY AND SAFETY. (25th March 2019) Authors: Auriemma, F.; Di Leo, M.; Comito, T.; Lamonaca, L.; Fugazza, A.; Anderloni, A.; Bossi, P.; Maselli, R.; Ferrara, E.C.; Galtieri, P.A.; Scorsetti, M.; Repici, A.; Carrara, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. PD-0546: Ten years critical re-evaluation of a Failure mode effect analysis in a radiotherapy department. (November 2020) Authors: Mancosu, P.; Signori, C.; Clerici, E.; Comito, T.; De Rose, F.; Ferrante, S.; Ferrara, M.; Galdieri, C.; Iftode, C.; Navarria, P.; Stravato, A.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. PD-0582 Phase II trial of SBRT for adrenal metastases: efficacy and impact on hormonal production. (May 2022) Authors: Franzese, C.; Stefanini, S.; Massaro, M.; Comito, T.; Navarria, P.; Clerici, E.; Teriaca, A.; Franceschini, D.; Reggiori, G.; Tomatis, S.; Lania, A.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. PO-0654: Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity. (April 2016) Authors: Navarria, P.; Ascolese, A.; D'agostino, G.; Villa, E.; Clerici, E.; Tozzi, A.; Iftode, C.; De Rose, F.; Liardo, L.; Comito, T.; Franzese, C.; Franceschini, D.; Pessina, F.; Riva, M.; Bello, L.; Reggiori, G.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. PO-0668: Stereotactic Body Radiation Therapy (SBRT) for lung metastatic patients with soft tissue sarcoma (STS). (April 2015) Authors: Navarria, P.; Ascolese, A.M.; De Rose, F.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Comito, T.; Villa, E.; Tomatis, S.; D'Agostino, G.R.; Reggiori, G.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. PO-0671: Influence of "radioresistant" histologies on SBRT outcome for lung metastases. (May 2017) Authors: Franceschini, D.; Cozzi, L.; De Rose, F.; Navarria, P.; D'Agostino, G.R.; Tomatis, S.; Franzese, C.; Comito, T.; Lobefalo, F.; Mancosu, P.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. PO-0705: Clinical outcomes for inoperable HCC treated with SBRT: results on 71 patients and 102 lesions. (April 2016) Authors: Comito, T.; Franzese, C.; Clerici, E.; De Rose, F.; Tozzi, A.; D'Agostino, G.; Navarria, P.; Iftode, C.; Villa, E.; Ascolese, A.M.; Franceschini, D.; Liardo, R.L.E.; Cozzi, L.; Foglliata, A.; Stravato, A.; Zucconi, F.; Reggiori, G.; Tomatis, S.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗